A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

NCT03130179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Tobacco Dependence

Interventions

DRUG: Nicorette Strongmint lozenge 4 mg
DRUG: Niquitin MiniMint lozenge 4 mg

Sponsor

McNeil AB